Effect of Introduction of the Pneumococcal Conjugate Vaccine on Drug-ResistantStreptococcus pneumoniae
Author(s) -
Moe H. Kyaw,
Ruth Lynfield,
William Schaffner,
Allen S. Craig,
James L. Hadler,
Arthur Reingold,
Ann Thomas,
Lee H. Harrison,
Nancy M. Bennett,
Monica M. Farley,
Richard R. Facklam,
James H. Jorgensen,
John M. Besser,
Elizabeth R. Zell,
Anne Schuchat,
Cynthia G. Whitney
Publication year - 2006
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa051642
Subject(s) - streptococcus pneumoniae , serotype , medicine , penicillin , pneumococcal conjugate vaccine , confidence interval , antibiotics , pneumococcal infections , conjugate vaccine , pneumococcal vaccine , microbiology and biotechnology , virology , biology
Five of seven serotypes in the pneumococcal conjugate vaccine, introduced for infants in the United States in 2000, are responsible for most penicillin-resistant infections. We examined the effect of this vaccine on invasive disease caused by resistant strains.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom